Literature DB >> 10627378

Successful lysis of right and left heart thrombus by tissue plasminogen activator.

K H Yeh1, K C Hung, F C Lin, S J Yeh, D Wu.   

Abstract

Tissue plasminogen activator (t-PA) was administered to three patients with newly developed intracardiac thrombi. Cases 1 and 2 developed right heart thrombi after radiofrequency ablation for atrioventricular nodal reentrant tachycardia and case 3 had tachycardia-related cardiomyopathy and a left ventricular thrombus. In all three patients, the intracardiac thrombi were successfully eliminated following t-PA therapy without major bleeding complications. These observations suggest that t-PA is effective in lysing new thrombus complicating radiofrequency ablation or heart failure and may be the therapy of choice in these conditions. Cathet. Cardiovasc. Intervent. 49:91-96, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627378     DOI: 10.1002/(sici)1522-726x(200001)49:1<91::aid-ccd22>3.0.co;2-b

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  4 in total

1.  End-stage heart failure with multiple intracardiac thrombi: a rescue strategy.

Authors:  Maximillian G Posch; Larry O Thompson; Michael M Koerner; Mehmet H Akay; George P Noon; Matthias Loebe
Journal:  Tex Heart Inst J       Date:  2004

2.  Thrombectomy reduces the systemic complications in device-related right atrial septic thrombosis.

Authors:  Siva Prasad Sontineni; Michael White; Sindhu Singh; Amy Arouni; David Cloutier; Chandra K Nair; Syed M Mohiuddin
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

3.  Fibrinolytic treatment in left ventricular mobile thrombi with low ejection fraction: results and follow-up of seven cases.

Authors:  Ibrahim Sari; Vedat Davutoğlu; Serdar Soydinc; Murat Sucu; Orhan Ozer
Journal:  J Thromb Thrombolysis       Date:  2007-05-11       Impact factor: 2.300

4.  Complete lysis of left ventricular giant thrombus with fibrinolytic therapy in clopidogrel resistant patient.

Authors:  Vedat Davutoglu; Serdar Soydinc; Yusuf Sezen
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.